nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Alterations in platelet secretion differentially affect thrombosis and hemostasis
|
Joshi, Smita |
|
|
2 |
17 |
p. 2187-2198 |
artikel |
2 |
A β1-tubulin–based megakaryocyte maturation reporter system identifies novel drugs that promote platelet production
|
Seo, Hideya |
|
|
2 |
17 |
p. 2262-2272 |
artikel |
3 |
Cobalt hematoporphyrin inhibits CLEC-2–podoplanin interaction, tumor metastasis, and arterial/venous thrombosis in mice
|
Tsukiji, Nagaharu |
|
|
2 |
17 |
p. 2214-2225 |
artikel |
4 |
Deciphering the differentiation trajectory from hematopoietic stem cells to mast cells
|
Grootens, Jennine |
|
|
2 |
17 |
p. 2273-2281 |
artikel |
5 |
Editorial Board
|
|
|
|
2 |
17 |
p. i |
artikel |
6 |
Enhancing immunotherapy of STING agonist for lymphoma in preclinical models
|
Sallets, Adrienne |
|
|
2 |
17 |
p. 2230-2241 |
artikel |
7 |
Espinoza JL, Elbadry MI, Chonabayashi K, et al. Hematopoiesis by iPSC-derived hematopoietic stem cells of aplastic anemia that escape cytotoxic T-cell attack. Blood Adv. 2018;2(4):390-400.
|
|
|
|
2 |
17 |
p. 2253 |
artikel |
8 |
Immune checkpoint inhibitors as a bridge to allogeneic transplantation with posttransplant cyclophosphamide
|
Schoch, Laura K. |
|
|
2 |
17 |
p. 2226-2229 |
artikel |
9 |
Is a matched unrelated donor search needed for all allogeneic transplant candidates?
|
Ciurea, Stefan O. |
|
|
2 |
17 |
p. 2254-2261 |
artikel |
10 |
Microenvironmental immune cell signatures dictate clinical outcomes for PTCL-NOS
|
Sugio, Takeshi |
|
|
2 |
17 |
p. 2242-2252 |
artikel |
11 |
Ravulizumab (ALXN1210) in patients with paroxysmal nocturnal hemoglobinuria: results of 2 phase 1b/2 studies
|
Röth, Alexander |
|
|
2 |
17 |
p. 2176-2185 |
artikel |
12 |
STAT5 is essential for IL-7–mediated viability, growth, and proliferation of T-cell acute lymphoblastic leukemia cells
|
Ribeiro, Daniel |
|
|
2 |
17 |
p. 2199-2213 |
artikel |
13 |
Wu V, Moshier E, Leng S, et al. Risk stratification of smoldering multiple myeloma: predictive value of free light chains and group-based trajectory modeling. Blood Adv. 2018;2(12):1470-1479.
|
|
|
|
2 |
17 |
p. 2186 |
artikel |